It is widely believed that testosterone therapy for men with low testosterone can lead to an increased risk of prostate cancer. Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School and author of the book Testosterone for Life, recalls the fascinating story of how this idea of high testosterone levels increasing the risk of prostate cancer originated, and suggests that in fact, the opposite might be true. What evidence supports boosting testosterone levels in men with low levels of the hormone, and that this might not raise a man's risk of developing prostate cancer? Hosted by Dr. Maurice Pickard.
Weighing Testosterone Therapy in Patients With Prostate Cancer

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
It is widely believed that testosterone therapy for men with low testosterone can lead to an increased risk of prostate cancer. Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School and author of the book Testosterone for Life, recalls the fascinating story of how this idea of high testosterone levels increasing the risk of prostate cancer originated, and suggests that in fact, the opposite might be true. What evidence supports boosting testosterone levels in men with low levels of the hormone, and that this might not raise a man's risk of developing prostate cancer? Hosted by Dr. Maurice Pickard.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?